Regulus Therapeutics Inc (RGLS)

[Majic]

Analysts' Revenue Estimates For Regulus Therapeutics Inc. (NASDAQ:RGLS) Are Surging Higher

"Regulus Therapeutics Inc. (NASDAQ:RGLS) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The consensus estimated revenue numbers rose, with their view now clearly much more bullish on the company's business prospects.

After this upgrade, Regulus Therapeutics' three analysts are now forecasting revenues of US$5.0m in 2020. This would be a major improvement in sales compared to the last 12 months. Losses are predicted to fall substantially, shrinking 37% to US$0.65. However, before this estimates update, the consensus had been expecting revenues of US$5.1m and US$0.51 per share in losses. So it's pretty clear the analysts have mixed opinions on Regulus Therapeutics even after this update; although they reconfirmed their revenue numbers, it came at the cost of a per-share losses."

Source; SimplyWallStreet